New Hope for Tough Lung Cancer Cases

Big news for anyone following cancer breakthroughs: the FDA just approved Emrelis, a new treatment for hard-to-treat lung cancer that targets tumors with too much c-Met protein. It’s a game-changer for folks whose cancer didn’t budge with standard therapies. Bonus: there’s a new test to see if you qualify. Early trial results look promising, but more studies are on the way. Heads up—there are some side effects, so talk to your doc if you’re interested! #LungCancer #FDAApproval #CancerResearch #HealthNews #Health